Adage Capital Partners Gp, L.L.C. Sutro Biopharma, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.9 Billion
- Q4 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 2,000,000 shares of STRO stock, worth $3.42 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,000,000
Previous 2,250,132
11.12%
Holding current value
$3.42 Million
Previous $7.79 Million
52.73%
% of portfolio
0.01%
Previous 0.01%
Shares
16 transactions
Others Institutions Holding STRO
# of Institutions
128Shares Held
59.9MCall Options Held
203KPut Options Held
33.6K-
Suvretta Capital Management, LLC New York, NY7.46MShares$12.8 Million0.57% of portfolio
-
Black Rock Inc. New York, NY6.91MShares$11.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.21MShares$7.2 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.64MShares$6.23 Million0.42% of portfolio
-
Vestal Point Capital, LP New York, NY2.57MShares$4.39 Million0.28% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $89.2M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...